These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
352 related items for PubMed ID: 21486698
1. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents. Liu XH, Ruan BF, Liu JX, Song BA, Jing LH, Li J, Yang Y, Zhu HL, Qi XB. Bioorg Med Chem Lett; 2011 May 15; 21(10):2916-20. PubMed ID: 21486698 [Abstract] [Full Text] [Related]
2. Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents. Liu XH, Liu HF, Chen J, Yang Y, Song BA, Bai LS, Liu JX, Zhu HL, Qi XB. Bioorg Med Chem Lett; 2010 Oct 01; 20(19):5705-8. PubMed ID: 20800480 [Abstract] [Full Text] [Related]
3. Synthesis and molecular docking studies of novel 2-chloro-pyridine derivatives containing flavone moieties as potential antitumor agents. Liu XH, Liu HF, Shen X, Song BA, Bhadury PS, Zhu HL, Liu JX, Qi XB. Bioorg Med Chem Lett; 2010 Jul 15; 20(14):4163-7. PubMed ID: 20538457 [Abstract] [Full Text] [Related]
4. Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents. Liu XH, Li J, Shi JB, Song BA, Qi XB. Eur J Med Chem; 2012 May 15; 51():294-9. PubMed ID: 22405648 [Abstract] [Full Text] [Related]
5. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents. Zhang XM, Qiu M, Sun J, Zhang YB, Yang YS, Wang XL, Tang JF, Zhu HL. Bioorg Med Chem; 2011 Nov 01; 19(21):6518-24. PubMed ID: 21962523 [Abstract] [Full Text] [Related]
6. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors. Zhang YB, Wang XL, Liu W, Yang YS, Tang JF, Zhu HL. Bioorg Med Chem; 2012 Nov 01; 20(21):6356-65. PubMed ID: 23018096 [Abstract] [Full Text] [Related]
7. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity. Wu XQ, Huang C, Jia YM, Song BA, Li J, Liu XH. Eur J Med Chem; 2014 Mar 03; 74():717-25. PubMed ID: 24119869 [Abstract] [Full Text] [Related]
8. Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors. Zhang H, Lu X, Zhang LR, Liu JJ, Yang XH, Wang XM, Zhu HL. Bioorg Med Chem; 2012 Feb 15; 20(4):1411-6. PubMed ID: 22277588 [Abstract] [Full Text] [Related]
10. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent. Sun J, Zhu H, Yang ZM, Zhu HL. Eur J Med Chem; 2013 Feb 15; 60():23-8. PubMed ID: 23279864 [Abstract] [Full Text] [Related]
11. Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects. Xiao X, Ni Y, Jia YM, Zheng M, Xu HF, Xu J, Liao C. Bioorg Med Chem Lett; 2016 Mar 15; 26(6):1508-1511. PubMed ID: 26883149 [Abstract] [Full Text] [Related]
12. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents. Huang XF, Lu X, Zhang Y, Song GQ, He QL, Li QS, Yang XH, Wei Y, Zhu HL. Bioorg Med Chem; 2012 Aug 15; 20(16):4895-900. PubMed ID: 22819191 [Abstract] [Full Text] [Related]
13. Design and synthesis of novel 2-methyl-4,5-substitutedbenzo[f]-3,3a,4,5-tetrahydro-pyrazolo[1,5-d][1,4]oxazepin-8(7H)-one derivatives as telomerase inhibitors. Liu XH, Jia YM, Song BA, Pang ZX, Yang S. Bioorg Med Chem Lett; 2013 Feb 01; 23(3):720-3. PubMed ID: 23265905 [Abstract] [Full Text] [Related]
14. Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors. Luo Y, Zhang S, Qiu KM, Liu ZJ, Yang YS, Fu J, Zhong WQ, Zhu HL. Bioorg Med Chem Lett; 2013 Feb 15; 23(4):1091-5. PubMed ID: 23312949 [Abstract] [Full Text] [Related]
15. Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo. Wang Y, Cheng FX, Yuan XL, Tang WJ, Shi JB, Liao CZ, Liu XH. Eur J Med Chem; 2016 Apr 13; 112():231-251. PubMed ID: 26900656 [Abstract] [Full Text] [Related]
16. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors. Chen Z, Wang ZC, Yan XQ, Wang PF, Lu XY, Chen LW, Zhu HL, Zhang HW. Bioorg Med Chem Lett; 2015 May 01; 25(9):1947-51. PubMed ID: 25866240 [Abstract] [Full Text] [Related]
17. Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents. Li X, Lu X, Xing M, Yang XH, Zhao TT, Gong HB, Zhu HL. Bioorg Med Chem Lett; 2012 Jun 01; 22(11):3589-93. PubMed ID: 22572580 [Abstract] [Full Text] [Related]
18. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives. Congiu C, Onnis V, Vesci L, Castorina M, Pisano C. Bioorg Med Chem; 2010 Sep 01; 18(17):6238-48. PubMed ID: 20702096 [Abstract] [Full Text] [Related]
19. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity. Shi JB, Tang WJ, Qi XB, Li R, Liu XH. Eur J Med Chem; 2015 Jan 27; 90():889-96. PubMed ID: 25554922 [Abstract] [Full Text] [Related]
20. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. Lv PC, Li DD, Li QS, Lu X, Xiao ZP, Zhu HL. Bioorg Med Chem Lett; 2011 Sep 15; 21(18):5374-7. PubMed ID: 21802290 [Abstract] [Full Text] [Related] Page: [Next] [New Search]